Tumor metastasis is closely involved with lymphatic vessels.
Metastatic melanoma cells rapidly migrate into lung via lymphatic vessels.
FLT4 antagonist, MAZ51 can induce impaired lymphatic endothelial cells without proliferation.
Melanoma metastasis into lung is inhibited by the suppression of FLT4-expressing lymphatic vessels, when MAZ51 treated.